Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Sheshadri Madhusudhana"'
Autor:
Rachel Yoder, Bruce F. Kimler, Joshua M. Staley, Kelsey Schwensen, Yen Y. Wang, Karissa Finke, Anne O’Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Robert Pluenneke, Sheshadri Madhusudhana, Larry Beck, Anuj Shrestha, Larry Corum, Mark Marsico, Shane R. Stecklein, Andrew K. Godwin, Qamar J. Khan, Priyanka Sharma
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Triple-negative breast cancer (TNBC) is classically defined by estrogen receptor (ER) and progesterone receptor (PR) immunohistochemistry expression
Externí odkaz:
https://doaj.org/article/cff802109f0d4e06a3ba6f327f1d9180
Autor:
Mugur Geana, Joseph Erba, Hope Krebill, Gary Doolittle, Sheshadri Madhusudhana, Abdulraheem Qasem, Nikki Malomo, Denise Sharp
Publikováno v:
Contemporary Clinical Trials Communications, Vol 5, Iss C, Pp 72-79 (2017)
Fewer than 5% of cancer patients participate in clinical trials, making it challenging to test new therapies or interventions for cancer. Even within that small number, patients living in inner-city and rural areas are underrepresented in clinical tr
Externí odkaz:
https://doaj.org/article/85de48cfcd6e432eb2f06a4a9e32c6e2
Autor:
Joseph M Unger, Lu Qian, Mary W Redman, Susan S Tavernier, Lori Minasian, Ellen V Sigal, Vassiliki A Papadimitrakopoulou, Michael Leblanc, Charles S Cleeland, Samuel A Dzingle, Thomas J Summers, Herta Chao, Sheshadri Madhusudhana, Liza Villaruz, Jeffrey Crawford, Jhanelle E Gray, Karen L Kelly, David R Gandara, Lyudmila Bazhenova, Roy S Herbst, Scott N Gettinger, Carol M Moinpour
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:437-446
Background An important issue for patients with cancer treated with novel therapeutics is how they weigh the effects of treatment on survival and quality of life (QOL). We compared QOL in patients enrolled to SWOG S1400I, a substudy of the LungMAP bi
Autor:
Qamar Khan, Kathan Mehta, Roberto Salgado, Andrew K. Godwin, Roy A. Jensen, Dinesh Pal Mudaranthakam, Milind Phadnis, Micki Prager, Stephanie LaFaver, Jaimie Heldstab, Larry Corum, Venkatadri Beeki, Vinay Raja, Robert Pluenneke, Richard McKittrick, Larry Beck, Anuj Shrestha, Deepti Satelli, Rajvi Shah, Karissa Finke, Roberto Rodriguez, Maureen Sheehan, Marc Hoffmann, Sheshadri Madhusudhana, Gregory Crane, Manana Elia, Christa Balanoff, Kelsey Larson, Amanda L. Amin, Jamie Wagner, Lindsey Prochaska, Joshua M. Staley, Rachel Yoder, Yen Y. Wang, Lauren Nye, Anne O'Dea, Bruce F. Kimler, Priyanka Sharma
NeoSTOP study schema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872284845c6fb7a024b1cc565d0a9fa5
https://doi.org/10.1158/1078-0432.22478366
https://doi.org/10.1158/1078-0432.22478366
Autor:
Qamar Khan, Kathan Mehta, Roberto Salgado, Andrew K. Godwin, Roy A. Jensen, Dinesh Pal Mudaranthakam, Milind Phadnis, Micki Prager, Stephanie LaFaver, Jaimie Heldstab, Larry Corum, Venkatadri Beeki, Vinay Raja, Robert Pluenneke, Richard McKittrick, Larry Beck, Anuj Shrestha, Deepti Satelli, Rajvi Shah, Karissa Finke, Roberto Rodriguez, Maureen Sheehan, Marc Hoffmann, Sheshadri Madhusudhana, Gregory Crane, Manana Elia, Christa Balanoff, Kelsey Larson, Amanda L. Amin, Jamie Wagner, Lindsey Prochaska, Joshua M. Staley, Rachel Yoder, Yen Y. Wang, Lauren Nye, Anne O'Dea, Bruce F. Kimler, Priyanka Sharma
Purpose:Addition of carboplatin (Cb) to anthracycline chemotherapy improves pathologic complete response (pCR), and carboplatin plus taxane regimens also yield encouraging pCR rates in triple-negative breast cancer (TNBC). Aim of the NeoSTOP multisit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2103dfe38658296b33b6c139aa71e167
https://doi.org/10.1158/1078-0432.c.6529934.v1
https://doi.org/10.1158/1078-0432.c.6529934.v1
Publikováno v:
Journal of Medical Cases. 13:219-224
Autor:
Vinay Raja, Micki Prager, Marc Hoffmann, Qamar J. Khan, Sheshadri Madhusudhana, Larry Beck, Lauren Nye, Rajvi H. Shah, Jaimie Heldstab, Dinesh Pal Mudaranthakam, Stephanie LaFaver, Roy A. Jensen, Roberto Rodríguez, Kelsey E. Larson, Gregory James Crane, Amanda L. Amin, Richard McKittrick, Venkatadri Beeki, Joshua M Staley, Lindsey Prochaska, Roberto Salgado, Maureen Sheehan, Rachel Yoder, Andrew K. Godwin, Manana Elia, Bruce F. Kimler, Larry Corum, Anuj Shrestha, Priyanka Sharma, Kathan Mehta, Christa R. Balanoff, Deepti Satelli, Jamie L. Wagner, Anne O'Dea, Milind A. Phadnis, Robert Pluenneke, Yen Y. Wang, Karissa Finke
Publikováno v:
Clin Cancer Res
Purpose: Addition of carboplatin (Cb) to anthracycline chemotherapy improves pathologic complete response (pCR), and carboplatin plus taxane regimens also yield encouraging pCR rates in triple-negative breast cancer (TNBC). Aim of the NeoSTOP multisi
Autor:
Ifrah Fatima, Mariam Haji, Wael T. Mohamed, Valerica Mateescu, Sheshadri Madhusudhana, Anuj Shrestha
Publikováno v:
American Journal of Gastroenterology. 117:e2046-e2047
Publikováno v:
The American Journal of Case Reports
Patient: Female, 46 Final Diagnosis: Rituximab induced acute thrombocytopenia Symptoms: Abdominal discomfort Medication: — Clinical Procedure: — Specialty: Hematology Objective: Adverse events of drug therapy Background: Rituximab is a chimeric m
Publikováno v:
Cureus
Multiple myeloma is a plasma cell neoplasm characterized by clonal proliferation of immunoglobulin producing terminally differentiated B cells. Classically patients are described to present with bone pain, hypercalcemia, anemia, and/or renal impairme